As Per Attachment

CIN : L10790RJ1991PLC006353 Date: 30/10/2026 The General Manager BSE Limited P.J. Towers, Dalal Street, Mumbai -400 001 Scrip ID: FRESITA Scrip Code: 519242 Subject: Outcome of Board Meeting held on 30th October, 2026 pursuant to Regulation 30 and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 30 and Regulation 33 read with other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of Fresita Proteins Limited, at its meeting held today, i.e., Friday, 30th October, 2026, at the Corporate Office of the Company situated at P-212 B, Gate No. 2, Lodhika GIDC, Rajkot – 360021, has considered and approved the following matters: 1. Approval of Unaudited Financial Results The Board of Directors considered and approved the Unaudited Standalone Financial Results of the Company for the quarter and half year ended 30th September, 2026, along with the Limited Review Report issued by the Statutory Auditors of the Company thereon. A copy of the aforesaid Unaudited Standalone Financial Results together with the Limited Review Report is enclosed herewith. 2. Shifting of Registered Office of the Company The Board of Directors considered and approved the proposal for shifting of the Registered Office of the Company from the State of Rajasthan (Alwar) to the State of Gujarat (Rajkot), subject to the approval of the shareholders of FRESITA PROTEINS LIMITED (Formerly Known as Sarda Proteins Limited) +91 63581 28991 Reg. Office : 2nd Floor, 2, Sai Collection Building, Bus Stand Road, Police Control Room, sardaproteins@yahoo.com | www.fresita.in Alwar Bus Stand Area, Alwar, Rajasthan – 301001 Corporate Office: P-212 B, Gate No. 2, Lodhika GIDC, Rajkot, Metoda, Gujarat, India – 360021 CIN : L10790RJ1991PLC006353 the Company and such other statutory and regulatory approvals as may be required under the applicable provisions of the Companies Act, 2013 and rules made thereunder. The meeting of the Board of Directors commenced at 05.00 P.M. and concluded at 05.35 P.M. Kindly take the above information on your records and acknowledge the receipt. Thanking you, Yours faithfully, For, Fresita Proteins Limited Shirish Dhirajlal Savaliya Managing Director DIN: 08721554 FRESITA PROTEINS LIMITED (Formerly Known as Sarda Proteins Limited) +91 63581 28991 Reg. Office : 2nd Floor, 2, Sai Collection Building, Bus Stand Road, Police Control Room, sardaproteins@yahoo.com | www.fresita.in Alwar Bus Stand Area, Alwar, Rajasthan – 301001 Corporate Office: P-212 B, Gate No. 2, Lodhika GIDC, Rajkot, Metoda, Gujarat, India – 360021 FRESITA PROTEINS LIMITED CIN: L10790RJ1991PLC006353 Reg Off: 2nd Floor, 2, Sai Collection Building, Bus Stand Road, Police Control Room, Alwar Bus Stand Area, Alwar Bus Stand, Alwar, Rajasthan, India, 301001 EMail: sardaproteins@yahoo.com, website: www.sardaproteins.com STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30th September, 2026 Rs.in Lakhs Half Year Half Year Quarter Ended on Year Ended ended on ended on Particulars 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 Un-Audited Un-Audited Un-Audited Un-Audited Un-Audited Audited I. Revenue from operations 81.03 1,299.30 430.38 1,380.33 1 ,525.84 1,615.84 II. Other Income - 548.10 10.54 548.10 1 0.62 3 4.98 III. Total Revenue (I+II) 81.03 1,847.40 440.92 1,928.43 1 ,536.46 1,650.82 IV. Expenses: Cost of Material Consumed - - - - - - Purchase of Stock -in- Trade 29.73 970.32 387.12 1,000.06 1 ,515.66 1,547.83 Changes in Inventories (Finished Goods, WIP, Stock-in-Trade) - - - - - - Employee Benefit Expenses 12.75 12.15 0.75 2 4.90 1.50 3 .00 Finance Cost - - - - - - Depreciation and Amoritsation Expenses - - - - - 0 .39 Other expenses 19.60 643.63 12.59 663.23 2 8.18 3 6.09 Total Expenses (IV) 62.08 1,626.10 400.45 1,688.19 1 ,545.34 1,587.32 V. Profit/(Loss) before Exceptional and Extraordinary Items and Tax (III-IV) 18.95 221.30 40.46 240.24 (8.88) 6 3.51 VI. Exceptional Items - - - - - - VII. Profit/(Loss) before Extraordinary Items and Tax (V-VI) 18.95 221.30 40.46 240.24 (8.88) 6 3.51 VIII. Extraordinary Items - - - - - - IX. Profit/(Loss) before Tax (V-VI) 18.95 221.30 40.46 240.24 (8.88) 6 3.51 X. Tax Expense: (1) Current Tax 5.00 55.33 - 6 0.33 - 1 8.07 (2) Deferred Tax - - - - - - XI. Profit/(Loss) for the period from Continuing Operations (VII-VIII) 13.95 165.97 40.46 179.91 (8.88) 4 5.44 XII. Profit/(Loss) from Discontinued Operations - - - - - - XIII. Tax Expenses of Discontinued Operations - - - - - - XIV. Profit/(Loss) from Discontinued Operations (after tax) (X-XI) - - - - - - XV. Profit/(Loss) for the period (IX+XII) 13.95 165.97 40.46 179.91 (8.88) 4 5.44 XVI. Other Comprehensive Income A (i) Items will not be reclassified to Profit or Loss - - - - - - (ii) Income Tax relating to items that will not be reclassified to Profit or Loss - - - - - - B (i) Items will be reclassified to Profit or Loss - - - - - - (ii) Income Tax relating to items that will be reclassified to Profit or Loss - - - - - - Total Comprehensive Income for the period (XIII+XIV)(Comprising Profit XVII. (Loss) and other comprehensive income for the period) 13.95 165.97 40.46 179.91 (8.88) 4 5.44 Paid up Equity Share Capital (Face Value of the Share-Rs. 10 Per Share) 89.76 89.76 17.26 8 9.76 1 7.26 8 9.76 XVIII Earnings per Equity Share (1) Basic 0.16 1.85 2.34 2 .00 (0.51) 0.51 (2) Diluted 0.16 1.85 2.34 2 .00 (0.51) 0.85 On behalf of the Board For, Fresita Proteins Limited Date :- 30.10.2026 SHIRISH DHIRAJLAL SAVALIYA Place :- Rajasthan Managing Director DIN: 08721554 FRESITA PROTEINS LIMITED CIN: L10790RJ1991PLC006353 Reg Off: 2nd Floor, 2, Sai Collection Building, Bus Stand Road, Police Control Room, Alwar Bus Stand Area, Alwar Bus Stand, Alwar, Rajasthan, India, 301001 EMail: sardaproteins@yahoo.com, website: www.sardaproteins.com BALANCE SHEET AS ON 30th September, 2026 (Amount in Lakhs) As at 30.09.2026 As at 31.03.2026 Sr. No. Particulars (In Rs.) (In Rs.) (Un-Audited) (Audited) I. ASSETS 1 Non-current assets - (a) Property, Plant & Equipments & Intengible Assets 1.33 0.60 (b) Financial Assets : (i) Investment - - (ii) Deffered Tax Asset 1 2.04 12.04 (iii) Loan & Advances 216.87 216.36 (iv) Others - Total Non-Current Asset 2 30.24 2 29.00 2 Current assets (a) Inventory - - (b) Financial Asset - - (i) Investment - - (ii) Trade Receivable 2 ,477.21 4 14.16 (iii) Cash and Cash equivalent 1 .90 7 51.93 (iv) Bank Balance other than (iii) above - - (v) Short Term Loan 7 ,258.96 7 ,258.23 (vi) Others (Advances) - - (c) Current Tax Assets (Net) - (d) Other Current Asset 1 5.87 1 2.20 Total Current Asset 9 ,753.95 8 ,436.52 TOTAL ASSET 9 ,984.18 8 ,665.52 II. EQUITY AND LIABILITIES A Equity (a) Share Capital 975.45 975.45 (b) Reserves and Surplus 7,825.22 7,645.29 Total Equity 8,800.67 8,620.74 B Liabilities 1 Non-Current Liabilities (a) Financial Liabilities - - (i) Borrowings - - (c) Deferred tax liabilities / Asset - - (d) Othe Non-Current Liabilities - - Total Non-Current Liabilities - - 2 Current Liabilities (a) Financial liabilities (i) Borrowings 1 5.50 1 5.50 (ii) Trade payables 1 ,058.75 3 .11 (A) total outstanding dues of micro enterprises and small enterprises - - (B) total outstanding dues of Creditors other than micro enterprises and small enterprises 1,058.75 3.11 (b) Other Current Liabilities - - (i) Duties & Taxes 2 8.98 9 .70 (c) Provisions 8 0.29 1 6.46 (d) Current Tax Liabilities (Net) - 0 .01 Total Current Liabilities 1 ,183.51 4 4.78 TOTAL EQUITY AND LIABILITIES 9 ,984.18 8 ,665.52 Notes :- TheaboveresultswereapprovedbyAuditCommitteeandbyBoardofDirectorsintheirmeetingheld on 30th October 2026 Theabovestatedresultshavebeenpreparedinaccordancewiththerecognitionandmeasurement 2 principlesofapplicableIndianAccountingStandardsandnotifiedunderCompaines(IndianAccounting Standards)Rules,2015(asame [Showing first 8,000 characters — download PDF for full document]